| Literature DB >> 24377096 |
A Smykla1, K Walewicz2, R Trybulski3, T Halski4, M Kucharzewski5, C Kucio6, W Mikusek7, K Klakla7, J Taradaj2.
Abstract
The aim of the study was to assess the efficacy of Kinesiology Taping (KT) for treating breast cancer-related lymphedema. Sixty-five women with unilateral stage II and III lymphedema were randomly grouped into the KT group (K-tapes, n = 20), the Quasi KT group (quasi K-tapes, n = 22), or the MCT group (multilayered compression therapy group, n = 23). Skin care, 45 min pneumatic compression therapy, 1 h manual lymphatic drainage, and application of K-tape/Quasi K-tapes/multilayered short-stretch bandages were given every treatment session, 3 times per week for 1 month. Patient evaluation items included limb size and percentage edema. Comparing the changes in K-tapes with quasi K-tapes changes, there were no significant differences (P > 0.05). The edema reduction of multilayered bandages was much better than in results observed in taping groups. The KT appeared to be ineffective at secondary lymphedema after breast cancer treatment. The single-blind, controlled pilot study results suggest that K-tape could not replace the bandage, and at this moment it must not be an alternative choice for the breast cancer-related lymphedema patient. The trial is registered with ACTRN12613001173785.Entities:
Mesh:
Year: 2013 PMID: 24377096 PMCID: PMC3860093 DOI: 10.1155/2013/767106
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Flow diagram of the study.
Figure 2Multilayered compression bandaging.
Figure 3Kinesiology Taping application.
Figure 4K-tapes technique.
Figure 5Optoelectronic limb volume measurement.
Figure 6Graphical presentation of optoelectronic measurement.
Characteristics of patients.
| Group KT | Group Quasi KT | Group MCT |
| |
|---|---|---|---|---|
| Number of women** | 20 | 22 | 23 | 0.784 |
| Age (years)** | ||||
| Range | 44–80 | 39–81 | 42–81 | 0.835 |
| Average | 67.34 | 65.43 | 66.45 | |
| Median | 66.11 | 63.89 | 67.81 | |
| SD | 12.03 | 13.13 | 11.99 | |
| Total mastectomy* | 20 | 22 | 23 | 0.784 |
| Number of patients with adipositas* (BMI > 30 kg/m2) | 7 | 7 | 6 | 0.812 |
| Smokers* | 7 | 8 | 7 | 0.812 |
| Chemotherapy* | 12 | 10 | 11 | 0.812 |
| Radiation therapy* | 15 | 13 | 13 | 0.788 |
| Side of lymphedema* | ||||
| Right | 8 | 10 | 10 | 0.679 |
| Left | 12 | 12 | 13 | |
| Duration of lymphedema (months)** | ||||
| Range | 12.2–63.6 | 12.3–46.6 | 15.3–33.8 | 0.621 |
| Average | 22.12 | 22.78 | 20.03 | |
| Median | 22.02 | 22.52 | 21.67 | |
| SD | 12.56 | 13.01 | 13.02 | |
| Lymphedema severity** (% compared to healthy limb) | ||||
| II stage (20–40%) | 15 | 16 | 16 | 0.788 |
| III stage (40–60%) | 5 | 6 | 7 |
*χ 2 test.
**Kruskal-Wallis test.
Results in percentage edema (affected upper limb compared to healthy limb volume and expressed in percent).
| Group | Average ± SD |
| ||
|---|---|---|---|---|
| Before therapy | After therapy | |||
| Decrease of edema (%) | KT | 31.03 ± 28.17 | 25.03 ± 23.08 |
|
| Quasi KT | 30.28 ± 30.12 | 24.47 ± 23.55 |
| |
| MCT | 31.07 ± 29.30 | 14.02 ± 10.03 |
| |
Wilcoxon test.
Figure 7Comparing percentage edema reduction between groups. KT versus MCT group (24.45% versus 53.21%, P = 0.02). Quasi KT versus MCT group (24.78% versus 53.21%, P = 0.02). KT versus Quasi KT group (24.45% versus 24.78%, P = 0.455).